Blue Sage Capital has successfully exited its investment in Controlled Recovery, selling the leading waste management facility to R360 Treatment, paving the way for future growth in a rapidly evolving industry.
Information on the Target
Controlled Recovery, commonly referred to as CRI, is recognized as the largest facility for non-hazardous oil and gas waste management in the United States. The company has established itself as a leader in the industry, providing essential services that cater to the growing demand for responsible waste disposal in the energy sector. As the majority controlling shareholder, Blue Sage Capital played a vital role in CRI's growth and operational success.
The recent sale of CRI to R360 Treatment not only exemplifies the company's value but also highlights the strategic positioning that CRI has achieved in the market. Peter Huff, a founding board member of CRI, noted that this transaction marks a significant opportunity for CRI to sustain its momentum in expansion while providing a strong return on investment for Blue Sage Capital.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the Target’s Specific Country
The oil and gas industry in the United States has been undergoing significant transformations, particularly in waste management practices. As environmental regulations tighten, companies ar
Similar Deals
JHBDMB Holdings, Inc. → BWFS Industries LLC
2025
Lime Rock Partners → A&B Valve
2024
Jim Guffey → ECS Geothermal
2023
F.N.B. Capital Partners, L.P. → Ullman Oil Company
2023
Bison → Cobalt Environmental Solutions
2023
Wellspring Capital Management LLC → Cadence Petroleum Group
2023
R360 Treatment
invested in
Controlled Recovery, Inc. (CRI)
in 2023
in a Management Buyout / Buy-In (MBO) deal